Hua Yi

Director/Board Member at Xiamen LP Pharmaceutical Co., Ltd.

50 year

Consumer Services

Health Technology

Process Industries

Profile

Hua Yi is currently a Director at CF PharmTech, Inc. and Xiamen LP Pharmaceutical Co., Ltd.
He previously held Director positions at HMT (Xiamen) New Technical Materials Co., Ltd.
and was a Non-Executive Director at TransThera Sciences (Nanjing), Inc. Dr. Yi earned doctorate degrees from East China Normal University and École normale supérieure Paris-Saclay.

Hua Yi active positions

Companies	Position	Start
Xiamen LP Pharmaceutical Co., Ltd. Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China.	Director/Board Member	2020-08-30
CF PharmTech, Inc CF PharmTech, Inc Medical SpecialtiesHealth Technology CF PharmTech, Inc engages in the research, development, production and sale of respiratory diseases pharmaceutical products. It mainly involves in complex product & platform, innovative medicines, medical devices, & provide technical services. The company offers inhalers, asthma treatment products including Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray. CF PharmTech was founded by Li LI in 2007 and is headquartered in Suzhou, China.	Director/Board Member	2021-11-30

All active positions of Hua Yi

Former positions of Hua Yi

Companies	Position	End
TransThera Sciences (Nanjing), Inc. TransThera Sciences (Nanjing), Inc. BiotechnologyHealth Technology TransThera Sciences (Nanjing), Inc. engages in the research and development of clinical biopharmaceutics. It focuses on the discovery and development of small molecule innovative therapies for tumors, inflammations, and cardiovascular diseases. The company was founded by Frank Wu on April 15, 2014 and is headquartered in Nanjing, China.	Director/Board Member	-
HMT (XIAMEN) NEW TECHNICAL MATERIALS CO., LTD	Director/Board Member	-

See the detail of Hua Yi's experience

Training of Hua Yi

East China Normal University	Doctorate Degree
École normale supérieure Paris-Saclay	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hua Yi's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
HMT (XIAMEN) NEW TECHNICAL MATERIALS CO., LTD	Process Industries

Private companies	3
TransThera Sciences (Nanjing), Inc. TransThera Sciences (Nanjing), Inc. BiotechnologyHealth Technology TransThera Sciences (Nanjing), Inc. engages in the research and development of clinical biopharmaceutics. It focuses on the discovery and development of small molecule innovative therapies for tumors, inflammations, and cardiovascular diseases. The company was founded by Frank Wu on April 15, 2014 and is headquartered in Nanjing, China.	Health Technology
Xiamen LP Pharmaceutical Co., Ltd. Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China.	Commercial Services
CF PharmTech, Inc CF PharmTech, Inc Medical SpecialtiesHealth Technology CF PharmTech, Inc engages in the research, development, production and sale of respiratory diseases pharmaceutical products. It mainly involves in complex product & platform, innovative medicines, medical devices, & provide technical services. The company offers inhalers, asthma treatment products including Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray. CF PharmTech was founded by Li LI in 2007 and is headquartered in Suzhou, China.	Health Technology

See company connections